Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21344 / DOSAGE - SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| FULVESTRANT(UNII: 22X328QOC4) (FULVESTRANT - UNII:22X328QOC4) | FULVESTRANT | 50mg in 1 |
Inactive Ingredients
| Ingredient Name | Accord Healthcare Inc. | AstraZeneca Pharmaceuticals LP | BluePoint Laboratories | EBEWE Pharma Ges.m.b.H. Nfg.KG | GLENMARK PHARMACEUTICALS INC., USA | HBT Labs, Inc. | Hikma Pharmaceuticals USA Inc. | Mylan Institutional LLC | Northstar RxLLC | Sagent Pharmaceuticals | Zydus Pharmaceuticals USA Inc. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALCOHOL(3K9958V90M) | |||||||||||
| BENZYL ALCOHOL(LKG8494WBH) | |||||||||||
| BENZYL BENZOATE(N863NB338G) | |||||||||||
| CASTOR OIL(D5340Y2I9G) |
